Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | GRIN1 | Q05586 | 9/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 9/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 8/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 8/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 8/20 | 0.46 |
| ▸ | GRIN2C | Q14957 | 8/20 | 0.46 |
| ▸ | GRIN3A | Q8TCU5 | 8/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14837319 | 0.86 | GRIN2D (0.57) | MEN1KMT2AGRIN1GRIN2AGRIN2D | |
| SCHEMBL2571225 | 0.86 | GRIN2D (0.52) | MEN1KMT2AGRIN1GRIN2AGRIN2D | |
| SCHEMBL4034262 | 0.85 | MEN1 (0.47) | MEN1KMT2AGRIN1GRIN2AGRIN2D | |
| SCHEMBL1940153 | 0.84 | MEN1 (0.63) | MEN1KMT2AGRIN1GRIN2AGRIN2D | |
| SCHEMBL25472233 | 0.80 | GRIN1 (0.52) | MEN1KMT2AGRIN1GRIN2AGRIN2D | |
| SCHEMBL986905 | 0.80 | GRIN1 (0.46) | MEN1KMT2AGRIN1GRIN2AGRIN2D | |
| SCHEMBL733948 | 0.80 | GRIN1 (0.52) | MEN1KMT2AGRIN1GRIN2AGRIN2D | |
| SCHEMBL11701304 | 0.79 | GRIN1 (0.60) | MEN1KMT2AGRIN1GRIN2AGRIN2D | |
| SCHEMBL11657544 | 0.74 | MEN1 (0.47) | MEN1KMT2AGRIN1GRIN2AGRIN2D | |
| SCHEMBL657398 | 0.74 | GRIN1 (0.75) | MEN1KMT2AGRIN1GRIN2AGRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8481016-B2 | Method for inhibition of potential-dependent cation channel | KAO CORPORATION (JP) | 2013-07-09 | — | — | US | disclosed |
| US-20130045177-A1 | Method for Inhibition of Potential-Dependent Cation Channel | KAO CORPORATION (JP) | 2013-02-21 | — | — | US | disclosed |
| EP-1258292-B1 | Oxidation catalytic system and oxidation process using same | DAICEL CHEM (JP) | 2004-05-19 | — | — | EP | disclosed |
| EP-0824962-B1 | USE OF AN OXIDATION CATALYST SYSTEM AND PROCESS FOR OXIDATION WITH THE SAME | DAICEL CHEM (JP) | 2003-05-07 | — | — | EP | disclosed |
| EP-0858835-B1 | Oxidation catalytic system and oxidation process | DAICEL CHEM (JP) | 2003-05-07 | — | — | EP | disclosed |
| CN-1098124-C | Oxidation catalyst system and process for oxidation with the same | DAICEL CHEM (JP) | 2003-01-08 | — | — | CN | disclosed |
| EP-1258292-A1 | Oxidation catalytic system and oxidation process using same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-11-20 | — | — | EP | disclosed |
| US-5981420-A | OXIDATION CATALYSTS SYSTEM CONSISTS OF AN N-HYDROXY OR N-OXY IMIDE COMPOUND AND A TRANSITION METAL COMPOUND EXCLUDING A POLYACID AS COCATALYST | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-11-09 | — | — | US | disclosed |
| US-5958821-A | EPOXIDATION OF AN ALKENE USING A CYCLIC N-HYDROXYIMIDE AND A COCATALYST OF A COMPOUND OF A GROUP 2A OR TRANSITION METAL USING OXYGEN; CATALYST SELECTIVITY; FREE OF PHOSPHO-VANADOMOLYBDIC ACID OR TETRAPHENYLPORPHYRINTOATO MANGANESE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-09-28 | — | — | US | disclosed |
| EP-0858835-A1 | Oxidation catalytic system and oxidation process | Daicel Chemical Industries, Ltd. (JP) | 1998-08-19 | — | — | EP | disclosed |
| EP-0144712-B1 | OPTICAL FIBER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-03-30 | — | — | EP | disclosed |
| US-4717756-A | HYDROPEROXIDE INITIATOR, SULFUR REDUCTANT, HYDROGEN HALOGENIDE SALT, COPPER COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-01-05 | — | — | US | disclosed |
| EP-0231395-A1 | PROCESS FOR PRODUCING METHACRYLATE POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-08-12 | — | — | EP | disclosed |
| EP-0217545-A1 | Method for the production of polymethacrylates | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-04-08 | — | — | EP | disclosed |
| EP-0190656-A2 | Method for producing plastic optical fiber with heat resistance | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-08-13 | — | — | EP | disclosed |
| US-4576438-A | Heat-resisting optical fiber | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-03-18 | — | — | US | disclosed |
| EP-0162472-A2 | Plastic optical fiber | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-11-27 | — | — | EP | disclosed |
| EP-0154339-A2 | Optical fiber | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-09-11 | — | — | EP | disclosed |
| EP-0144712-A2 | Optical fiber | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-06-19 | — | — | EP | disclosed |
| EP-0097325-A2 | Optical fiber | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045177-A1 | Method for Inhibition of Potential-Dependent Cation Channel | TRPM7, TRPM8, OR10J3 | MEN1 2194/4885KMT2A 3964/4885GRIN1 215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.